SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-23-000052
Filing Date
2023-11-08
Accepted
2023-11-08 16:11:16
Documents
87
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q jazz-20230930.htm   iXBRL 10-Q 1711350
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32023ex311.htm EX-31.1 10266
3 CERTIFICATION OF INTERIM PFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq32023ex312.htm EX-31.2 10407
4 CERTIFICATIONS OF CEO AND INTERIM PFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq32023ex321.htm EX-32.1 7098
  Complete submission text file 0001232524-23-000052.txt   8815708

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20230930.xsd EX-101.SCH 55897
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20230930_cal.xml EX-101.CAL 105460
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20230930_def.xml EX-101.DEF 297226
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20230930_lab.xml EX-101.LAB 774882
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20230930_pre.xml EX-101.PRE 508923
81 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20230930_htm.xml XML 1357118
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 231387953
SIC: 2834 Pharmaceutical Preparations